-
OPDIVO (Nivolumab) 40mg/4mL online
OPDIVO is a programmed death receptor-1 (PD-1) blocking antibody indicated for the treatment of advanced Lung Cancer, Melanoma, advanced Kidney Cancer, Head and Neck Squamous Cell Cancer, Advanced Liver Cancer, Advanced Bladder Cancer, Colorectal Cancer and Classical Hodgkin Lymphoma.
866.00 per Vial
$866.00 -
Crizocent（XALKORI）Crizotinib 250mg online
Crizocent （XALKORI）is also known as Bangladesh Generic XALKORI （crizotinib）
$996.00 -
-
-
-
-
XOVOLTIB (Afatinib) 50mg online
Embryo-fetal toxicity: Can cause fetal harm when administered to a pregnant woman. Advise pregnant women and females of reproductive potential of the potential risk to the fetus and to use effective
1,398.00 per 28 Tablets
$1,398.00XOVOLTIB (Afatinib) 50mg online
$1,398.00 -
Luciolap（lynparza）Olaparib 50mg online
in patients with deleterious or suspected deleterious gBRCAm, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting. Patients with hormone receptor (HR)-positive breast cancer should have been treated with a prior endocrine therapy or be considered inappropriate for endocrine therapy. Select patients for therapy based on an FDA-approved companion diagnostic for Luciolap.
1,399.00 per 112 Tablets
$1,399.00Luciolap（lynparza）Olaparib 50mg online
$1,399.00
